IonQ’s investment thesis is neutral-to-bullish, supported by a full-stack platform strategy and a $1B-plus commercial ...
Dosed First Patient in REVEAL Pivotal Trial in the Fourth Quarter of 2025. Additional enrollment continues to advance across ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to Reached written alignment with FDA on inclusion of =3 months of safety data from ASPIRE trial evaluating TSHA-102 (N=3 ...
Morning Overview on MSN
Scientists build a ‘periodic table’ for AI models
Scientists are trying to tame the chaos of modern artificial intelligence by doing something very old fashioned: drawing a ...
John Deere agrees to acquire Tenna, expanding mixed-fleet equipment tracking and construction operations technology. Deal ...
What if we trained mental capacity the same way we train physical fitness: through reps, metrics, and practice?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback